# Sutro Biopharma, Inc.: Form 8-K, filed Apr 27, 2023

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: 8-K
- Filed: 2023-04-27
- Accepted by EDGAR: Apr 27, 2023, 16:31 ET
- Period: 2023-04-24
- Accession: 0000950170-23-015323
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000095017023015323/stro-20230424.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000095017023015323/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000095017023015323/stro-20230424.htm

Filed Apr 27, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-015323. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.